Seeking Alpha

Enzon Pharmaceuticals (ENZN): Q4 EPS of -$0.11. Revenue of $10.6M. (PR)

Enzon Pharmaceuticals (ENZN): Q4 EPS of -$0.11. Revenue of $10.6M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)